-
Dyngo-4a for T Cell Endocytosis Research
2026-09-29
Dyngo-4a gives researchers a controlled way to test whether dynamin-dependent uptake contributes to lipid nanoparticle mRNA delivery in human T cells. Used alongside viability, uptake, and protein-expression assays, this dynamin inhibitor can separate entry defects from formulation or electroporation toxicity.
-
Idoxuridine Workflow for Viral DNA Assays
2026-09-29
Build more informative antiviral experiments with Idoxuridine, a nucleoside analog that links viral DNA synthesis inhibition to orthogonal genome, infectivity, and cell-health measurements. This workflow emphasizes stock handling, assay controls, time-resolved readouts, and careful separation of antiviral activity from nonspecific toxicity.
-
Naftifine HCl Research Workflows
2026-09-28
Build more interpretable antifungal assays with Naftifine HCl, from solvent-controlled stock preparation to orthogonal sterol and viability readouts. A workflow inspired by multi-modal pathway research helps separate target-proximal effects from nonspecific growth inhibition while keeping fungal and muscle-biology applications scientifically distinct.
-
Cell Divisions Refine—and Challenge—Embryonic Boundaries
2026-09-28
Castle and colleagues show that ectodermal cell divisions have a context-dependent mechanical effect at the Drosophila mesectoderm–ectoderm boundary: divisions can promote mixing when actomyosin tension is compromised, yet normally help sharpen the interface. Combining mathematical modeling with in vivo perturbations, laser ablation, and cell tracking, the study identifies cell-division-driven tissue fluidity as a contributor to boundary refinement.
-
SETD7 Loss Promotes White Fat Browning in Obese Mice
2026-09-27
The study identifies SETD7 as a negative regulator of thermogenic programming in inguinal white adipose tissue, linking its depletion to greater browning and improved outcomes in obese mice. Its findings point to an adipocyte-intrinsic mechanism involving Adcy7, Sirt1, and CREB1, while leaving important questions about translation, tissue specificity, and therapeutic targeting open.
-
Crystal Violet Staining for Translational Phenotypes
2026-09-26
Crystal Violet Staining Solution can make cell-based phenotypes easier to visualize, but translational value comes from matching the stain to the biological question. We explore how endpoint staining, orthogonal validation, and pathogen-lineage context can strengthen research decisions without overstating what a dye can reveal.
-
Cy5-UTP Workflow for Fluorescent RNA Probes
2026-09-25
Learn how to incorporate Cy5-UTP during T7 in vitro transcription for directly detectable RNA probes, with practical guidance for labeling-ratio optimization, quality control, and FISH. The workflow also explains how fluorescent RNA can support delivery studies without confusing RNA tracking with proof of intact, functional mRNA.
-
Dyngo-4a in Serial T-Cell Engineering Research
2026-09-25
Serial lipid nanoparticle delivery can support repeated mRNA engineering while preserving more viable T cells than electroporation, but the trafficking steps behind that performance remain an open question. Use Dyngo-4a as a carefully controlled mechanistic probe—not as an established way to improve LNP transfection—to test whether dynamin-dependent uptake contributes to your workflow.
-
dKeap1–Lamin Dm0 Links to Nuclear Architecture
2026-09-24
Carlson and colleagues report a molecular and genetic relationship between Drosophila Keap1 (dKeap1) and the B-type lamin Dm0, connecting xenobiotic-response signaling with nuclear organization. Their findings associate dKeap1 misregulation with altered lamin localization, heterochromatin-marker distribution, and nuclear-lamina morphology, while leaving the underlying mechanism and broader transferability open for testing.
-
Caspase-4 Colorimetric Assay Kit in ER-Stress Studies
2026-09-24
Connect organelle-targeted cancer research with a practical, quantitative readout of LEVD-dependent caspase-4 activity. This guide explains how to use the assay in pyroptosis-focused experiments—without mistaking ER stress or cell death for proof of caspase-4 activation.
-
Tamoxifen Beyond ER: Radiation and Tumor Immunity
2026-09-23
Tamoxifen is best known as a selective estrogen receptor modulator, but new preclinical findings point to an additional role in radiation-driven tumor immunity. This article examines the evidence, experimental implications, and limits for translational research.
-
ER-Targeted Peptide Self-Assembly in Cancer Cells
2026-09-23
The reference study develops an alkaline phosphatase-triggered peptide that self-assembles at the endoplasmic reticulum, selectively stressing cancer cells with elevated alkaline phosphatase expression. ER localization improves activity relative to non-targeted intracellular assembly, lowering the reported IC50 by more than twofold while promoting apoptosis and necroptosis.
-
From Plaque Biology to Quantitative Immunodetection
2026-09-22
A translational framework for converting causal atherosclerosis evidence into reproducible immunofluorescence, immunohistochemistry, flow cytometry, and ELISA workflows using a spectrally defined goat anti-rabbit secondary antibody.
-
FGFR1 as a Druggable Target in Schizophrenia
2026-09-22
This 2025 Molecular Neurobiology study integrates genetic causal inference, colocalization, SMR validation, phenome-wide screening, drug prediction, molecular docking, and single-cell expression analysis to prioritize therapeutic targets for schizophrenia. Six genes were implicated, with FGFR1 emerging as the most actionable candidate, although the findings remain a preclinical target-discovery framework rather than evidence of clinical efficacy.
-
Antiangiogenic Airway Stents for Tracheal Restenosis
2026-09-21
Zhao and colleagues developed an electrospun airway stent that combines anlotinib hydrochloride with silver nanoparticles to address infection, inflammation, angiogenesis, and fibroblast activation in tracheal in-stent restenosis. Material testing, cell studies, rabbit implantation, and RNA sequencing collectively support a multitarget strategy, while also highlighting the need for longer-term and clinically comparative validation.